Note - This session is a total of 45 minutes, and therefore .75 contact hours; however, the CNE evaluation for this session includes a reflection that you must complete (questions are required) that allows you an extra .25 contact hours - bringing your contact hour total for this session to 1.00.
Contact hours available until 4/16/2016.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure: Speakers have no disclosures to declare.
Planning Committee: • Annette Hood discloses that she is a member of the Amgen speakers’ bureau. • Denise Murcek discloses other financial/material support as an employee of the VA Medical Center. • Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care. • Kyra Trappett discloses other financial/material support as an employee of DaVita.
Commercial Support and Sponsorship: Supported by an educational grant from Sanofi Renal
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Describe the provisions of the final rule for the prospective payment system. • Discuss the impact of the PPS provisions on dialysis services. • Analyze the risk factors and laboratory values that can impact the development of hypercalcemia in the CKD patient. • Recognize effective treatment strategies to minimize hypercalcemia in the individual with CKD or incident to hemodialysis/peritoneal dialysis.